PER 1.41% 7.0¢ percheron therapeutics limited

Note; ... ANP is assessing potential next development and...

  1. 404 Posts.
    Note;
    ... ANP is assessing potential next development and commercialisation steps for ATL1103 in consultation with its technical and regulatory experts ...

    I think we can also expect news on 1103 in the near future. Like to think FDA (AT1103) is still on the cards.. Restructuing of XLT and board members may also be a reality... Watch this space, exciting times ahead (IMO)
    Last edited by GoldStriker: 09/03/16
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.